Design Therapeutics, Inc. (DSGN) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Design Therapeutics, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -7.71x | -7.04x | -2.22x | -9.03x | -27.68x | -136.25x |
| P/B Ratio | 2.53x | 1.44x | 0.53x | 1.75x | 2.57x | -99.70x |
| P/S Ratio | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Profitability | ||||||
| Gross Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| EBITDA Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 17.14x | 29.31x | 29.58x | 31.10x | 72.96x | 15.55x |
| Quick Ratio | 17.14x | 29.31x | 29.58x | 31.10x | 72.96x | 15.55x |
| Leverage | ||||||
| Debt/Equity | 0.00x | 0.01x | 0.01x | 0.01x | 0.01x | 0.00x |
YoY = year-over-year change. Source: FMP..